Format

Send to

Choose Destination
See comment in PubMed Commons below
Am J Public Health. 1999 Mar;89(3):351-7.

Radon and lung cancer: a cost-effectiveness analysis.

Author information

  • 1National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA, USA. esf2@cdc.gov

Abstract

OBJECTIVES:

This study examined the cost-effectiveness of general and targeted strategies for residential radon testing and mitigation in the United States.

METHODS:

A decision-tree model was used to perform a cost-effectiveness analysis of preventing radon-associated deaths from lung cancer.

RESULTS:

For a radon threshold of 4 pCi/L, the estimated costs to prevent 1 lung cancer death are about $3 million (154 lung cancer deaths prevented), or $480,000 per life-year saved, based on universal radon screening and mitigation, and about $2 million (104 lung cancer deaths prevented), or $330,000 per life-year saved, if testing and mitigation are confined to geographic areas at high risk for radon exposure. For mitigation undertaken after a single screening test and after a second confirmatory test, the estimated costs are about $920,000 and $520,000, respectively, to prevent a lung cancer death with universal screening and $130,000 and $80,000 per life-year for high risk screening. The numbers of preventable lung cancer deaths are 811 and 527 for universal and targeted approaches, respectively.

CONCLUSIONS:

These data suggest possible alternatives to current recommendations.

PMID:
10076484
PMCID:
PMC1508623
[PubMed - indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Write to the Help Desk